MetLife Investment Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.05M | Buy |
|
|||||
|
2025
Q2 | $1.03M | Buy |
|
|||||
|
2025
Q1 | $783K | Sell |
|
|||||
|
2024
Q4 | $1.01M | Buy |
|
|||||
|
2024
Q3 | $900K | Buy |
|
|||||
|
2024
Q2 | $901K | Buy |
|
|||||
|
2024
Q1 | $719K | Hold |
|
|||||
|
2023
Q4 | $712K | Hold |
|
|||||
|
2023
Q3 | $552K | Hold |
|
|||||
|
2023
Q2 | $539K | Hold |
|
|||||
|
2023
Q1 | $481K | Hold |
|
|||||
|
2022
Q4 | $556K | Hold |
|
|||||
|
2022
Q3 | $768K | Hold |
|
|||||
|
2022
Q2 | $587K | Buy |
|
|||||
|
2022
Q1 | $458K | Buy |
|
|||||
|
2021
Q4 | $706K | Buy |
|
|||||
|
2021
Q3 | $247K | Buy |
|
|||||
|
2021
Q2 | $318K | Buy |
|